Trial intelligence / Profile preview

Fast Release Aspirin in Postsurgical Dental Pain

NCT01117636Phase 3Completed

Sponsor
Bayer
Start
Apr 2010
Primary completion
Jul 2010
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of aspirin in odontalgia (3 arms), sponsored by Bayer. Primary endpoints: Time to First Perceptible Pain Relief (PR) and Time to First Perceptible Pain Relief (PR) Confirmed. Started Apr 2010; status: completed.

02

Drugs

aspirin
03

Conditions

odontalgia

Beyond the preview

Go deeper on NCT01117636.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01117636.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call